A global agenda for older adult immunization in the COVID-19 era: a roadmap for action
LA Privor-Dumm, GA Poland, J Barratt, DN Durrheim… - Vaccine, 2021 - Elsevier
Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of
building a global system that can support both routine and pandemic/epidemic adult …
building a global system that can support both routine and pandemic/epidemic adult …
[HTML][HTML] Older adults' perspectives on a COVID-19 vaccine
PN Malani, E Solway, JT Kullgren - JAMA Health Forum, 2020 - jamanetwork.com
As of December 4, 2020, cases of novel coronavirus disease 2019 (COVID-19) have topped
14.3 million in the US with nearly 300 000 associated deaths. While mitigation measures …
14.3 million in the US with nearly 300 000 associated deaths. While mitigation measures …
[HTML][HTML] Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017
MT Aguado, J Barratt, JR Beard, BB Blomberg… - Vaccine, 2018 - Elsevier
Many industrialized countries have implemented routine immunization policies for older
adults, but similar strategies have not been widely implemented in low-and middle-income …
adults, but similar strategies have not been widely implemented in low-and middle-income …
[HTML][HTML] COVID-19 mortality and progress toward vaccinating older adults—World Health Organization, worldwide, 2020–2022
MK Wong - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
COVID-19 vaccines are safe and reduce COVID-19 mortality. The World Health
Organization (WHO) recommends that countries prioritize populations at increased risk, eg …
Organization (WHO) recommends that countries prioritize populations at increased risk, eg …
The impact of immuno-aging on SARS-CoV-2 vaccine development
The SARS-CoV-2 pandemic has almost 56 million confirmed cases resulting in over 1.3
million deaths as of November 2020. This infection has proved more deadly to older adults …
million deaths as of November 2020. This infection has proved more deadly to older adults …
Development and deployment of COVID-19 vaccines for those most vulnerable
WC Koff, T Schenkelberg, T Williams… - Science translational …, 2021 - science.org
Development of safe and effective COVID-19 vaccines is a global priority and the best hope
for ending the COVID-19 pandemic. Remarkably, in less than 1 year, vaccines have been …
for ending the COVID-19 pandemic. Remarkably, in less than 1 year, vaccines have been …
Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond
B Weinberger - Immunity & Ageing, 2021 - Springer
Preserving good health in old age is of utmost importance to alleviate societal, economic
and health care-related challenges caused by an aging society. The prevalence and …
and health care-related challenges caused by an aging society. The prevalence and …
[HTML][HTML] Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization …
AS Wallace, TK Ryman, L Privor-Dumm, C Morgan… - Vaccine, 2022 - Elsevier
Abstract Strategic Priority 4 (SP4) of the Immunization Agenda 2030 aims to ensure that all
people benefit from recommended immunizations throughout the life-course, integrated with …
people benefit from recommended immunizations throughout the life-course, integrated with …
[HTML][HTML] Review of COVID-19 vaccines and their evidence in older adults
SP Teo - Annals of geriatric medicine and research, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant …
syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant …
Efficacy and safety of COVID-19 vaccines in older people
RL Soiza, C Scicluna, EC Thomson - Age and ageing, 2021 - academic.oup.com
Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of
regulatory approval. Their safety and efficacy in older people is critical to their success. Even …
regulatory approval. Their safety and efficacy in older people is critical to their success. Even …